Medifast (NYSE: MED) reported Q1 EPS of ($0.19), $0.17 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $76 million versus the consensus estimate of $85.5 million.

For earnings history and earnings-related data on Medifast (MED) click here.